Navigation Links
Novartis marks World CML Day with update on global research program to evaluate whether Ph+ CML patients can live treatment-free
Date:9/19/2013

EAST HANOVER, N.J., Sept. 19, 2013 /PRNewswire/ -- Novartis commemorates World CML Day by announcing the latest milestone in its unique clinical trial program evaluating the potential for patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) to maintain undetectable levels of disease after stopping drug therapy – a concept called treatment-free remission. More than 100 study sites are now enrolling patients to the trial program.

Since 2008, organizations around the world have recognized World CML Day1. The date, September 22 or 9/22, was chosen to symbolically represent the genetic material that is associated with CML – the missing section from chromosome 22 shifts to chromosome 9 and vice versa, in a phenomenon called "translocation2." Known as the Philadelphia chromosome, this genetic mutation is present in about 95% of CML patients3.

"As a leader in CML, Novartis is proud to support World CML Day through our continued dedication to ongoing research in this disease," said Herve Hoppenot, President, Novartis Oncology. "We are now exploring if the disease can be treated to a point where drug therapy is no longer needed, representing the next step in what may be possible for patients living with Ph+ CML."

Over the past decades, Novartis research in Ph+ CML has helped transform the disease from a fatal diagnosis to a chronic condition for many patients. Today, the company continues its long-standing commitment to the global CML community. The Novartis treatment-free remission clinical trial program[*] includes eight studies that are now underway and actively enrolling Ph+ CML patients in more than 100 global sites across 40 countries.

_______________________________________
[*] In the Novartis treatment-free remission
'/>"/>

SOURCE Novartis
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Global Lung Cancer Therapeutics Market 2013 Report Featuring Leading Players Such As AstraZeneca, Bristol-Myers Squibb, Eli Lilly and Co., GlaxoSmithKline, Hoffmann-La Roche, Novartis And Others
2. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
3. Leaders from Pfizer, Novartis and J&J Challenge Industry to Disrupt R&D
4. Novartis launches the Cancer Cell Line Encyclopedia to catalog worlds cancer cell lines
5. Plaintiff Sales Representatives and Novartis Pharmaceuticals Corporation Resolve Class Action Wage and Hour Claims
6. Novartis Highlights Advances for Patients With Breast Cancer and Hematological Diseases With Over 160 SABCS and ASH Abstracts
7. Spanish researchers writing in cell describe the 9 hallmarks of aging
8. Discovery of gene mutation causing Sturge-Weber syndrome, port-wine stain birthmarks offers new hope
9. Nutra Pharma Patent and Trademarks Published in India
10. Spider Bully for Less: My Cleaning Products Marks Down the Spray for its Christmas Special
11. My Cleaning Products Marks Down Its Bed Bug Bully Price by 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... 19, 2014 The “Human Insulin ... Intermediate Acting, Premixed), Modern Human Insulin (Rapid Acting, ... NovoRapid, Novomix, Tresiba, Others) - Forecast to 2018” ... restraints, challenges, opportunities, current market trends, and strategies ... the estimates and forecasts of the revenue and ...
(Date:10/18/2014)... October 18, 2014 The Asia-Pacific hardware ... market in Asia-Pacific with analysis and forecast of revenue. ... is expected to reach $51,362.6 million by 2018, at ... Browse through the TOC of the Asia-Pacific hardware encryption ... analysis provided. This also provides a glimpse of the ...
(Date:10/18/2014)... According to a new market research report ... Global Trends & Forecasts up till 2017”, hydraulic fracturing ... This value is expected to increase from $40 billion ... CAGR during the same period. North America is expected ... terms of hydraulic horse power supplied by the year ...
(Date:10/17/2014)... journey through the looking-glass to Wonderland, mirrors in the ... ways, including a new class of mirror that works ... The Optical Society,s (OSA) new high-impact journal ... time, a new type of mirror that forgoes a ... by using an unusual magnetic property of a non-metallic ...
Breaking Biology Technology:Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 2Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 3Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 4Medical Human Insulin Market Is Expected to Reach $42 billion by 2019 - New Research Report by MarketsandMarkets 5The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 2Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 3Hydraulic Fracturing Market Projected To Reach $64 Billion by 2017 - New Report by MarketsandMarkets 4Magnetic mirrors enable new technologies by reflecting light in uncanny ways 2Magnetic mirrors enable new technologies by reflecting light in uncanny ways 3Magnetic mirrors enable new technologies by reflecting light in uncanny ways 4
... Energy, manufacturer of Reuter Stokes radiation detection equipment, has ... and software associated with the SNS 8Pack neutron detector ... neutron detectors developed at Oak Ridge National Laboratory. ... system that was developed for the Department of Energy,s ...
... June 3 Xceed Molecular, a pioneer ... has granted Gen-Probe Incorporated (Nasdaq: GPRO ... use Xceed,s novel Flow-Thru Chip,technology. Gen-Probe expects ... multiplexed molecular-diagnostics products. Gen-Probe is a,global leader ...
... June 3 ViroPharma Incorporated,(Nasdaq: VPHM ) ... officer of ViroPharma, will present at the Goldman ... PDT on Tuesday, June 10,2008. The conference is ... Point, CA., ViroPharma also announced that William ...
Cached Biology Technology:GE Energy to market SNS-developed detector electronics system 2Xceed Molecular Grants Gen-Probe License to Xceed's Flow-Thru Chip(R) Technology for Multiplex Molecular Diagnostics 2ViroPharma to Present at Two Upcoming Healthcare Conferences 2
(Date:10/15/2014)... assess the pandemic risk from strains of influenza virus ... allow ourselves to become complacent that the most substantial ... scientists. , Influenza pandemics arise when a new virus ... widespread immunity – spreads in the human population. There ... years, the worst of which – the 1918 Spanish ...
(Date:10/15/2014)... bacterial pneumonia in female mice to an enzyme activated ... naturally more resistant to respiratory infections than males. Now, ... resistance to bacterial pneumonia in female mice is linked ... also show that this enzyme is ultimately activated by ... The team, lead by Professor Lester Kobzik at the ...
(Date:10/14/2014)... N.C. – Like discriminating thieves, prostate cancer tumors scavenge ... the body. But such avarice may be a fatal ... a way to kill prostate cancer cells by delivering ... selectively destroys the diseased cells brimming with the mineral, ... uses two drugs already commercially available for other uses, ...
Breaking Biology News(10 mins):Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Prostate cancer's penchant for copper may be a fatal flaw 2
... N.Y., won the ninth-annual IEEE-USA Best Communications System ... Competition National Finals on Wednesday. Farnsworth ... communications system" at the Hyatt Regency Washington on ... Zubin Mukerjee, Abigail Schooner and Joseph Sipzner; engineer-mentor ...
... colleagues in the palaeontology and biomechanics research group have reconstructed ... (Stan at the Manchester Museum and the Museum of the ... Strutiomimum sedens and an Edmontosaurus annectens . ... of Science journal PLoS ONE today (19th February ...
... senior, has been named the first Churchill Scholar at the ... a one-year graduate program at Cambridge University, where he will ... Juneja, a mechanical engineering major, has maintained a near ... Last spring when he was about to graduate his academic ...
Cached Biology News:New York, Florida schools win awards at national student competition 2'Fattysaurus' or 'thinnysaurus'? How dinosaurs measure up with laser imaging 2'Fattysaurus' or 'thinnysaurus'? How dinosaurs measure up with laser imaging 3UC San Diego senior named Churchill Scholar for extraordinary undergraduate research 2UC San Diego senior named Churchill Scholar for extraordinary undergraduate research 3
...
... to Decorin ( Abpromise for ... Antigen: Synthetic peptide: IGPEVPDDRDFEPS conjugated ... 6-19 of Human Decorin (fragment 36-49 ... II). Entrez GeneID: ...
... Introducing the NEW VSOS-4P, all Programmable and Digital ... has now been redesigned to make every day ... a Programmable memory for up to 4 different ... entry of your program. Furthermore, the VSOS-4P has ...
... Antibody Validation Service enables early selection ... development by providing quantitative data for ... of each antibody. Furthermore quantitative antibody ... off-target activity of your antibodies., The ...
Biology Products: